上巨实业医疗 HOLX 深 沪
等待开盘 04-01 09:30:00 美东时间
75.59
+0.040
+0.05%
华盛通- 最 高75.67
- 今 开75.65
- 成交量 261.47万股
- 最 低 75.51
- 昨 收 75.55
- 总市值 168.75亿
- 52周最高 75.78
- 市盈率 静 30.41
- 换手率 1.17%
- 52周最低 51.90
- 委 比 20.66%
- 总股本 2.23亿
- 历史最高 87.88
- 量 比 1.01
- 振 幅 0.21%
- 历史最低 13.90
- 每 手 1
- 风险率 6.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多RadNet Makes $270 Million Bet On AI Future With Gleamer Buyout
RadNet (RDNT) reports record Q4 revenue and adjusted EBITDA, beating estimates and announcing acquisition of Paris-based AI firm Gleamer.
03-02 21:31
豪洛捷或面临黑石集团收购，重申2026财年业绩指引
经济观察网 豪洛捷（Hologic）可能面临收购可能性及财务业绩指引等动向。 近期事件 收购可能性：黑石集团重新对豪洛捷提起收购兴趣，若交易推进，可能引发公司控...
02-19 07:30
中国批准黑石和TPG以183亿美元收购Hologic
（来源：欧洲并购与投资） 中国批准黑石和TPG以183亿美元收购Hologic 图片来源：handshakestudios.com 根据中国国家市...
02-12 14:16
China regulator approves Blackstone, TPG acquisition of medtech firm Hologic
China regulator approves Blackstone, TPG acquisition of medtech firm Hologic BEIJING, Feb 10 (Reuters) - China has approved private equity firms Blackstone BX.N and TPG's TPG.O acquisition of medical diagnostics firm Hologic HOLX.O , according to a list of deal approvals from the country's market re
02-10 09:16
Hologic Inc. hielt eine Sonderversammlung der Aktionäre ab
Hologic Inc. hielt eine Sonderversammlung der Aktionäre ab Hologic Inc. hat am 5. Februar 2026 eine außerordentliche Hauptversammlung abgehalten. Dem Vorschlag zur Übernahme durch Hopper Parent Inc. wurde zugestimmt. Ein weiterer Vorschlag zur Vergütung der leitenden Führungskräfte im Zusammenhang m
02-06 21:01
Hologic Inc. Held Special Shareholder Meeting for Proposed Acquisition
Hologic Inc. Held Special Shareholder Meeting for Proposed Acquisition Hologic Inc. held a special meeting of stockholders on February 5, 2026. At the meeting, stockholders approved the proposed acquisition of Hologic Inc. by affiliates of funds managed by Blackstone Inc. and TPG Global, LLC. An adv
02-06 21:01
Hologic Announces Its Aptima HPV Assay Gets FDA Approval For Clinician-Collected HPV Primary Screening
Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima® HPV Assay received FDA approval for clinician-collected HPV primary screening. Hologic's human papillomavirus (HPV) test is the only FDA-approved
02-04 21:23
LIVE MARKETS-LPL Financial now among possible S&P 500 additions
LIVE MARKETS-LPL Financial now among possible S&P 500 additions Main US indexes rise; Dow out front, up ~1% Staples leads S&P 500 sector gainers; Energy weakest group Euro STOXX 600 index up 1% Dollar up; bitcoin rallies >3%; gold falls ~4%; crude slides ~5% US 10-Year Treasury yield rises to ~4.27%
02-03 01:06
Hologic Q1 Adj. EPS $1.04 Misses $1.09 Estimate, Sales $1.048B Miss $1.070B Estimate
Hologic (NASDAQ:HOLX) reported quarterly earnings of $1.04 per share which missed the analyst consensus estimate of $1.09 by 4.94 percent. This is a 0.97 percent increase over earnings of $1.03 per share from the same
01-30 05:02
BRIEF-Hologic Q1 Adjusted EBITDA USD 330.4 Million Vs. IBES Estimate USD 338.5 Million
BRIEF-Hologic Q1 Adjusted EBITDA USD 330.4 Million Vs. IBES Estimate USD 338.5 Million Jan 29 (Reuters) - Hologic Q1 adjusted EPS USD 1.04 vs. IBES estimate USD 1.09. Q1 revenue USD 1,047.8 million vs. IBES estimate USD 1,070 million Q1 EPS USD 0.79 Q1 adjusted net income USD 235.5 million vs. IBES
01-30 05:02
